- ALK opjusterer forventningerne til omsætning og indtjening i 2024
- ALK upgrades its full-year revenue and earnings outlook
- ALK provides update on regulatory process for the house dust mite allergy tablet in China
- ALK giver opdatering på registreringsprocessen for tabletten mod husstøvmideallergi i Kina
- ALK launches new growth strategy and 2028 financial ambitions
- ALK lancerer ny vækststrategi og finansielle ambitioner for 2028
- ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies
- ALK’s European registration application for ITULAZAX® for paediatric indication accepted for review
- Listen in on ALK’s Capital Markets Day on 4 June 2024
- Three-month interim report (Q1) 2024 (unaudited)
More ▼
Key statistics
On Thursday, ALK-Abello A/S (ALK B:CPH) closed at 152.90, -4.38% below its 52-week high of 159.90, set on Jun 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 153.00 |
---|---|
High | 153.90 |
Low | 151.70 |
Bid | 152.90 |
Offer | 152.90 |
Previous close | 153.30 |
Average volume | 378.27k |
---|---|
Shares outstanding | 202.57m |
Free float | 112.81m |
P/E (TTM) | 61.51 |
Market cap | 31.05bn DKK |
EPS (TTM) | 2.49 DKK |
Data delayed at least 15 minutes, as of Jul 04 2024 16:10 BST.
More ▼